News | Robotic Systems

Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published by The Lancet, has published the results from the Telerobotic Intervention Study, the world’s first percutaneous coronary intervention (PCI) procedures conducted from a remote location outside the catheterization lab. The study was conducted using Corindus’ CorPath technology platform.

Home September 03, 2019
Home
Technology | Vascular Access

New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven, it is placed to provide an ideal work surface for antegrade femoral approach during interventional radiology vascular procedures. The device sits within the company’s existing range of access and patient positioning devices designed for interventional radiology, cardiology and vascular procedures.

Home September 03, 2019
Home
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home September 03, 2019
Home
News | Cardiac Imaging

Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019, Aug. 31–Sept. 4 in Paris, France. At the congress, Philips is showcasing Release 5.0 of its Epiq CVx cardiology platform for the first time in Europe. The platform includes automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct. Philips also announced that it is collaborating with digital health company LindaCare to combine the latter’s OnePulse cloud-based solution for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) with the Philips IntelliSpace Cardiovascular informatics platform.

Home August 30, 2019
Home
InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.
Feature | ECG Wireless Remote Access | Stuart Long and Colin Movsowitz, M.D.

Until recently, cardiologists trying to diagnose and treat arrhythmias have had to deal with technological limitations ...

Home August 30, 2019
Home
News | Cybersecurity

Use of the Internet of Things (IoT) is booming, with IHS Markit forecasting there will be 73 billion connected devices in use around the world by 2025. IoT technology has moved beyond speakers and smart fridges and is increasingly being utilized for critical applications across the healthcare industry like insulin delivery devices, connected inhalers and even cancer treatments.

Home August 29, 2019
Home
News | Artificial Intelligence

In the near future, doctors may be able to apply artificial intelligence (AI) to electrocardiogram data in order to measure overall health status, according to new research. The study was published in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

Home August 29, 2019
Home
Blog | Wearables

Atrial fibrillation, or Afib, kills about 130,000 people worldwide every year. It also affects 3 to 6 million people in ...

Home August 29, 2019
Home
News | Hemostasis Management

Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial compression device. The PreludeSync Evo is a sterile, single-use, disposable device used to assist in gaining hemostasis of the arterial percutaneous access site following catheterization procedures.

Home August 29, 2019
Home
FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices
Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor

The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the safety of paclitaxel-coated devices used to treat peripheral artery disease (PAD) following its review of long-term follow-up clinical data. The agency said five-year results from three randomized trials showed an increased mortality rate in patients treated with these devices compared to those treated with uncoated devices. While these data provide reason for caution, the FDA noted that the devices still provide documented short-term benefits, and healthcare providers should consider all options for their PAD patients.

Home August 28, 2019
Home
News | Left Atrial Appendage (LAA) Occluders

AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional labeling claims for AtriClip left atrial appendage (LAA) management devices. These include changing the indication from occlusion of the LAA to exclusion, and also adding electrical isolation as a labeling claim.

Home August 28, 2019
Home
News | Magnetic Resonance Imaging (MRI)

A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of Warwick focuses on hierarchical template matching (HTM) to diagnose cardiac disease without the use of gadolinium contrast. The technique is explored in an article in the journal Scientific Reports.

Home August 28, 2019
Home
News | Cath Lab

Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy heart muscle tissue.

Home August 27, 2019
Home
News | EP Lab

Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of heartbeat abnormalities. The facility, which includes a brand new procedural laboratory, will offer patients a state-of-the-art program delivering cutting-edge electrophysiology procedures, including complex ablations, minimally-invasive pacemaker and defibrillator implantations, and structural interventions. The space also includes a newly renovated reception area and a comfortable, tranquil waiting room for patients’ families and friends.

Home August 27, 2019
Home
News | Peripheral Artery Disease (PAD)

Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for below-the-knee (BTK) use of its MagicTouch drug-coated balloon catheter (DCB) for the treatment of peripheral artery disease (PAD). The company is now in a position to potentially disrupt this market and become a threat to larger manufacturers that have an established presence in the peripheral space, according to data and analytics company GlobalData.

Home August 27, 2019
Home
Subscribe Now